Australia markets closed

Scopus BioPharma Inc. (SCPS)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.00030.0000 (0.00%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,265
2,682
15,023
7,424
463.112
Selling general and administrative
4,078
9,033
12,611
2,732
2,227
Total operating expenses
9,343
11,715
27,635
10,156
2,690
Operating income or loss
-9,343
-11,715
-27,635
-10,156
-2,690
Interest expense
-
0
774.679
706.446
0
Total other income/expenses net
-
-
1,456
-
-
Income before tax
-9,343
-11,715
-26,953
-10,862
-2,690
Income from continuing operations
-9,343
-11,715
-26,953
-10,862
-2,690
Net income
-8,696
-11,610
-26,953
-10,862
-2,690
Net income available to common shareholders
-8,696
-11,610
-26,953
-10,862
-2,690
Basic EPS
-0.31
-0.55
-1.56
-0.81
-0.18
Diluted EPS
-0.31
-0.55
-1.56
-0.81
-0.18
Basic average shares
28,088
21,094
17,252
13,363
14,976
Diluted average shares
28,088
21,094
17,252
13,363
14,976